Endress+Hauser and Finesse Solutions form strategic partnership
Back To [Archive]
Swiss process automation
provider invests in US biotech companyProcess automation specialist
Endress+Hauser has acquired a stake in Finesse Solutions, a US company that develops, produces and
distributes sensors, hardware and software for bioprocess engineering
Endress+Hauser intends to strengthen its position in the area of biotechnology through
this cooperation. "Biotechnological procedures will play an increasingly important role in the
future, not only in the life sciences industry but also in other industries such as the chemical
industry to manufacture products in a more environmentally friendly and economical fashion,"
emphasizes Klaus Endress, CEO of the Endress+Hauser Group. "Our partnership with Finesse offers us
the possibility of gaining experience in this area without neglecting our core
business."Combined offers for
Finesse Solutions will profit from leveraging the know-how of the new strategic
relationship to extend its product portfolio and to enhance its global sales and service
capabilities. The two companies intend to cooperate closely in relation to products, markets and
customers, and to complement each other, for example, in the provision of global after-market
services to bioprocess end users. "Endress+Hauser and Finesse Solutions have many common customers
who can profit from this cooperation," stated Finesse CEO Barbara A Paldus.
majority shareholder, Skymoon Ventures, will hold an equal stake to Endress+Hauser. The company's
staff of about 50 will maintain their ownership in the company. Endress+Hauser will elect two
representatives to the Board of Directors, which Barbara A Paldus will continue to chair.